Capturing missed HIV pre-exposure prophylaxis opportunities-sexually transmitted infection diagnoses in the emergency department

被引:3
|
作者
Mclaughlin, Stephanie E. [1 ]
Kapadia, Farzana [2 ]
Greene, Richard E. [1 ]
Pitts, Robert [1 ]
机构
[1] New York Univ Langone, Dept Med, New York, NY USA
[2] NYU, Dept Epidemiol, Sch Global Publ Hlth, New York, NY USA
关键词
prevention; other; HIV (human immunodeficiency virus); viral disease; North America; location;
D O I
10.1177/09564624211048671
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The United States Centers for Disease Control and Prevention (CDC) recommends HIV pre-exposure prophylaxis (PrEP) be considered for all patients diagnosed with a sexually transmitted infection (STI). Emergency departments (EDs) are an important site for diagnosis and treatment of STIs for under-served populations. Consequently, we identified 377 patients diagnosed with a bacterial sexually transmitted infection (gonorrhea, chlamydia, and/or syphilis) at a major New York City emergency department between 1/1/2014 and 7/30/2017 to examine associations between key sociodemographic characteristics and missed opportunities for PrEP provision. In this sample, 299 (79%) emergency department patients missed their medical follow-up 90 days after STI diagnosis, as recommended. Results from adjusted generalized estimating equation regression models indicate that patients >45 yo (aOR = 2.2, 95% CI 1.2-3.9) and those with a primary care provider in the hospital system (aOR = 6.8, 95% CI 3.8-12.0) were more likely to return for follow-up visits, whereas Black patients (aOR = 0.44, 95% CI 0.25-0.77) were less likely to return for follow-up visits. These findings indicate that lack of STI treatment follow-up visits are significantly missed opportunities for PrEP provision and comprehensive human immunodeficiency virus prevention care.
引用
收藏
页码:242 / 246
页数:5
相关论文
共 50 条
  • [31] HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021
    Marcus, Ulrich
    Schink, Susanne B.
    Weber, Christoph
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [32] Preferences and acceptability of testing for sexually transmitted infections in an HIV pre-exposure prophylaxis clinic in Hanoi, Vietnam
    Bui, H. T. M.
    Adamson, P. C.
    Nguyen, T. C.
    Dau, N. S.
    Nguyen, K. D.
    Pham, L. Q.
    Le, G. M.
    Klausner, J. D.
    SEXUAL HEALTH, 2024, 21 (04) : 111 - 112
  • [33] Comparative analysis of sexually transmitted infections among people living with HIV and pre-exposure Prophylaxis users
    Ramos-Ruperto, L.
    De Gea-Grela, A.
    Fernandez-Hinojal, F.
    Arcos-Rueda, M.
    Delgado-Hierro, A.
    Quiles, I.
    Maldonado-Barrueco, A.
    Busca-Arenzana, C.
    Mican, R.
    de Miguel, R.
    Montejano, R.
    Valencia, E.
    Montes, M. L.
    Martin-Carbonero, L.
    Bernardino, J. I.
    HIV MEDICINE, 2023, 24 : 546 - 546
  • [34] Recurrence of sexually transmitted infections is commonly found in a subpopulation of Austrian users of HIV pre-exposure prophylaxis
    Urban, Nikolaus
    Neidhart, Thomas
    Grabmeier-Pfistershammer, Katharina
    Touzeau-Roemer, Veronique
    Schmidt, Kaspar Laurenz
    Strassl, Robert
    Weninger, Wolfgang
    Willinger, Birgit
    Bauer, Wolfgang Michael
    Chromy, David
    WIENER KLINISCHE WOCHENSCHRIFT, 2025,
  • [35] Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis
    Zeggagh, Jeremy
    Bauer, Rebecca
    Delaugerre, Constance
    Carette, Diane
    Fressard, Lisa
    Charreau, Isabelle
    Chidiac, Christian
    Pialoux, Gilles
    Tremblay, Cecile
    Cua, Eric
    Robineau, Olivier
    Raffi, Francois
    Capitant, Catherine
    Spire, Bruno
    Meyer, Laurence
    Molina, Jean Michel
    AIDS, 2022, 36 (08) : 1129 - 1134
  • [36] Preferences and Acceptability of Testing for Sexually Transmitted Infections in an HIV Pre-Exposure Prophylaxis Clinic in Hanoi, Vietnam
    Bui, Hao T. M.
    Adamson, Paul C.
    Nguyen, Thanh C.
    Dau, Nguyen S.
    Nguyen, Khanh D.
    Pham, Loc Q.
    Le, Giang M.
    Klausner, Jeffrey D.
    SEXUALLY TRANSMITTED DISEASES, 2025, 52 (04) : 242 - 247
  • [37] Stampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDS
    Uckun, Fatih M.
    Cahn, Pedro
    Qazi, Sanjive
    D'Cruz, Osmond
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (04) : 489 - 500
  • [38] Incidence of sexually transmitted infections during pre-exposure prophylaxis for HIV: a worrying outcome at 2 years!
    Ducours, Mailys
    Alleman, Laure
    Puges, Mathilde
    Deborde, Matthieu
    Hessamfar, Mojgan
    Le-Marec, Fabien
    Dabis, Francois
    Pereyre, Sabine
    Bebear, Cecile
    Descaux, Arnaud
    Cazanave, Charles
    SEXUALLY TRANSMITTED INFECTIONS, 2019, 95 (07) : 552 - 552
  • [39] PRE-EXPOSURE PROPHYLAXIS (PREP) ELIGIBILITY IN THE PEDIATRIC EMERGENCY DEPARTMENT
    Dimenstein, Nicholas
    Badolato, Gia
    Duling, Emma
    Kaushal, Natasha
    Boyle, Meleah
    Rosenthal, Eric
    Chamberlain, James
    Dowshen, Nadia
    Goyal, Monika
    JOURNAL OF ADOLESCENT HEALTH, 2025, 76 (03)
  • [40] Does pre-exposure prophylaxis increase the risk of acquiring sexually transmitted infections?
    Colas, M.
    Vanhaecke, C.
    Courtieu, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (01) : 7 - 7